Provided are stable pharmaceutical formulations of benzimidazole compounds, particularly esomeprazole magnesium, and processes for their preparation

Details for Australian Patent Application No. 2005257977 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Shterman, Nava; Moshe, Benny; Itah, Esther; Di Capua, Simona

Agent Shelston IP

Pub. Number AU-A-2005257977

PCT Pub. Number WO2006/002077

Priority 60/580,273 15.06.04 US; 60/588,233 14.07.04 US; 60/591,784 27.07.04 US

Filing date 15 June 2005

Wipo publication date 5 January 2006

International Classifications

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/4439 (2006.01)

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002077 Priority application(s): WO2006/002077

18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257978-Methods and apparatus for extinguishing fires

2005257952-Method of improving animal tissue quality by supplementing the animal diet with oleic acid and selected tocols